Proposed framework regarding management of patients with breast cancer and anti-cancer treatment-related elevation in cardiac troponin
Cardiac biomarkers are a vital component within the first edition of the European Society of Cardiology guidelines in Cardio-Oncology. Specifically, they are mentioned in the definition of mild asymptomatic cancer therapy-related cardiac dysfunction, where left ventricular systolic function is ≥50 %...
Saved in:
| Main Authors: | Michael Cronin, Dina Neiroukh, Aoife Lowery, William Wijns, Michael Kerin, Maccon Keane, Silvie Blazkova, Osama Soliman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | International Journal of Cardiology: Heart & Vasculature |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S235290672400188X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-Induced Rhabdomyolysis with Elevated Cardiac Troponin T
by: Gro Egholm, et al.
Published: (2015-01-01) -
Cardiac Troponin Elevation Predicts Mortality in Patients Undergoing Orthotopic Liver Transplantation
by: David Snipelisky, et al.
Published: (2013-01-01) -
Exercise‐Induced Cardiac Troponin I Elevation Is Associated With Regional Alterations in Left Ventricular Strain in High‐Troponin Responders
by: Christine Bjørkvik Erevik, et al.
Published: (2024-08-01) -
Elevated Troponin and Jarisch-Herxheimer Reaction in Tick-Borne Relapsing Fever: A Case Report
by: Kenneth A. Hoekstra, et al.
Published: (2011-01-01) -
Incidence and prognosis associated with troponin elevation after cardiac surgery: a prospective cohort study
by: Arthur Clement, et al.
Published: (2022-08-01)